We are live on
!
Find out more
GCM
Ghisallo Capital Management Portfolio holdings
AUM
$5.1B
1-Year Est. Return
39.13%
This Fund
S&P 500
This Quarter
Est. Return
+15.09%
1 Year Est. Return
+39.13%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.89%
10 Year Est. Return
–
AUM
$5.1B
AUM Growth
+$1.47B
(+40%)
Cap. Flow
+$410M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
42.59%
Holding
458
New
148
Increased
12
Reduced
51
Closed
123
Avg Time Held
1.3
quarters
Top 10 Avg Time Held
0.3
quarters
Top 20 Avg Time Held
0.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$965M |
| 2 |
Digital Realty Trust
DLR
|
+$229M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$144M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$143M |
| 5 |
Super Micro Computer
SMCI
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$102M |
| 2 |
NVIDIA
NVDA
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$92.5M |
| 4 |
GlobalFoundries
GFS
|
+$80.1M |
| 5 |
Medline Inc
MDLN
|
+$62.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 29.61% |
| 2 | Miscellaneous | 19.42% |
| 3 | Communication Services | 10.49% |
| 4 | Technology | 8.11% |
| 5 | Healthcare | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Silver Bow Mining Corp
SBMT
$213M
| $676K | 0.01% |
+100,000
| New | +$884K |
2026 Q2
0 quarters
|
|
|
PBLS
277
Parabilis Medicines Inc
PBLS
$3.32B
| $547K | 0.01% |
+20,000
| New | +$552K |
2026 Q2
0 quarters
|
|
278
Seaport Therapeutics
SPTX
$861M
| $543K | 0.01% |
+25,000
| New | +$440K |
2026 Q2
0 quarters
|
|
279
Peabody Energy
BTU
$3.07B
| $532K | 0.01% |
+23,000
| New | +$611K |
2026 Q2
0 quarters
|
|
280
ITG Inc
ITG
$363M
| $528K | 0.01% |
+33,000
| New | +$528K |
2026 Q2
0 quarters
|
|
281
Spring Valley Acquisition Corp IV
SVIV
$309M
| $510K | 0.01% |
+50,000
| New | +$503K |
2026 Q2
0 quarters
|
|
282
Inflection Point Acquisition Corp. VII Class A Ordinary Shares
IPXG
$316M
| $507K | 0.01% |
+50,000
| New | +$497K |
2026 Q2
0 quarters
|
|
283
Meshflow Acquisition Corp
MESH
$435M
| $501K | 0.01% |
50,000
| – | – |
2026 Q1
1 quarter
|
|
284
Odyssey Therapeutics
ODTX
$829M
| $468K | 0.01% |
+25,000
| New | +$438K |
2026 Q2
0 quarters
|
|
285
Jade Biosciences
JBIO
$853M
| $444K | 0.01% |
+20,000
| New | +$417K |
2026 Q2
0 quarters
|
|
286
Keel Infrastructure Corp
KEEL
$1.77B
| $435K | 0.01% |
+75,700
| New | +$325K |
2026 Q2
0 quarters
|
|
287
Humacyte
HUMA
$99.7M
| $390K | 0.01% |
+500,000
| New | +$463K |
2026 Q2
0 quarters
|
|
288
New America Acquisition I Corp
NWAX
$500M
| $305K | 0.01% |
30,000
| – | – |
2026 Q1
1 quarter
|
|
289
BitGo Holdings
BTGO
$823M
| $259K | 0.01% |
50,000
-30,000
| -38% | -$246K |
2026 Q1
1 quarter
|
|
290
HCM III Acquisition Corp
HCMA
$348M
| $257K | 0.01% |
25,000
| – | – |
2025 Q3
3 quarters
|
|
291
Ocean Capital Acquisition Corp Units
OCAC.U
| $256K | 0.01% |
+25,000
| New | +$255K |
2026 Q2
0 quarters
|
|
292
Corvus Pharmaceuticals
CRVS
$792M
| $149K | ﹤0.01% |
10,000
| – | – |
2026 Q1
1 quarter
|
|
293
Viridian Therapeutics
VRDN
$2.06B
| $129K | ﹤0.01% |
+7,000
| New | +$113K |
2026 Q2
0 quarters
|
|
|
AVAT
294
Avalanche Treasury Corp
AVAT
$50.4M
| $101K | ﹤0.01% |
+201,924
| New | +$193K |
2026 Q2
0 quarters
|
|
295
Infinite Eagle Acquisition Corp Rights
IEAGR
| $87.8K | ﹤0.01% |
450,000
| – | – |
2026 Q1
1 quarter
|
|
296
Hennessy Capital Investment Corp VIII Share Rights
HCICR
| $80.5K | ﹤0.01% |
+500,000
| New | +$82.2K |
2026 Q2
0 quarters
|
|
297
Drugs Made In America Acquisition II Corp Right
DMIIR
| $54.5K | ﹤0.01% |
750,000
| – | – |
2025 Q4
2 quarters
|
|
298
SPACSphere Acquisition Corp Rights
SSACR
| $33.8K | ﹤0.01% |
+200,000
| New | +$33.9K |
2026 Q2
0 quarters
|
|
299
Apogee Acquisition Corp Rights
AACPR
| $22.5K | ﹤0.01% |
+125,000
| New | +$24K |
2026 Q2
0 quarters
|
|
300
XFLH Capital Corp Rights
XFLH.RT
| $10.3K | ﹤0.01% |
+100,000
| New | +$11K |
2026 Q2
0 quarters
|
|
Similar funds
KACA
MRCP
CFO
YCM
BPCE
GIBU
ACM
BMO
Ghisallo Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Ghisallo Capital Management held 458 positions worth $5.1B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Ghisallo Capital Management deployed $410M of net new capital in Q2 2026, opening 148 new positions and adding to 12 existing holdings. Its largest new stake was SpaceX: 5,678,145 shares worth $970M.
By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Communication Services.
On the sell side, the largest reduction was Medline Inc, an estimated $62.3M trimmed.
- Ghisallo Capital Management's largest Q2 2026 buy was SpaceX: 5,678,145 shares worth $970M.
- Ghisallo Capital Management added most to Diamondback Energy in Q2 2026, an estimated $29.1M increase.
- Ghisallo Capital Management's biggest Q2 2026 reduction was Medline Inc, cutting an estimated $62.3M.
- Ghisallo Capital Management fully exited Tesla in Q2 2026, selling an estimated $102M.
- Ghisallo Capital Management's ten largest holdings make up 43% of its $5.1B portfolio in Q2 2026.
- Ghisallo Capital Management opened 148 new positions and closed 123 in Q2 2026.
- Ghisallo Capital Management's portfolio value rose 40% quarter-over-quarter to $5.1B.
Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.